· Fan PW, Song Y, Berezhkovskiy LM, Cheong J, Plise EG, Khojasteh SC. Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery. Future Med Chem. 2014;6(18) : 1995-2012.
· Roberto Menichetti, Kiran H. Kanekal, and Tristan Bereau, “Drug–Membrane Permeability across Chemical Space”, ACS Central Science 2019 5 (2), 290-298
· Kusuhara H, Sugiyama Y. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Drug Metab. Rev. 42(3), 2010, 539–550
· Murray S. Webb, Jeffery J. Wheeler, Marcel B. Bally, Lawrence D. Mayer, 「The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: Implications for drug delivery」, Biochimica et Biophysica Acta (BBA) - Biomembranes, Volume 1238, Issue 2, 1995, 147-155
· Angelis, Isabella De, and Laura Turco. “Caco-2 cells as a model for intestinal absorption, 「Current protocols in toxicology」 vol. Chapter 20 Unit20.6, 2011
· Peng Y, Yadava P, Heikkinen AT, Parrott N, Railkar A. 「Applications of a 7-day Caco-2 cell model in drug discovery and development.」, Eur J Pharm Sci. 2014;56:120-130.
· van Breemen, R. B., & Li, Y., 「Caco-2 cell permeability assays to measure drug absorption. Expert opinion on drug metabolism & toxicology」, 1(2), 2005, 175–185.
· Smetanová L, Stĕtinová V, Svoboda Z, Kvetina J. 「Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver」. Acta Medica (Hradec Kralove). 2011;54(1):3-8.
· 고운정, 천은파, 한효경, 「In-Vitro 흡수특성 검색 모델로서 Caco-2 및 MDCK 세포배양계의 특성 비교 평가」, 약제학회지, 38(3), 2008, 183-189
· 정경희, 김영찬, 「소장 상피 세포주를 이용한 투과성 예측」, 공정기술연구단, Bulletin of Food Technology
· Vol.26, No.2, pp. 102-108